Retinal Microvascular Changes in Patients with Chronic Heart Failure due to Idiopathic Dilated Cardiomyopathy
PDF
Cite
Share
Request
Original Research
VOLUME: 8 ISSUE: 2
P: 161 - 166
June 2023

Retinal Microvascular Changes in Patients with Chronic Heart Failure due to Idiopathic Dilated Cardiomyopathy

Bagcilar Med Bull 2023;8(2):161-166
1. Kızılay Kağıthane Hospital, Clinic of Ophthalmology, İstanbul, Turkey
2. University of Health Sciences Turkey, Şişli Hamidiye Etfal Training and Research Hospital, Clinic of Ophthalmology, İstanbul, Turkey
3. University of Health Sciences Turkey, Başakşehir Çam and Sakura City Hospital, Clinic of Ophthalmology, İstanbul, Turkey
4. Osmaniye State Hospital, Clinic of Ophthalmology, Osmaniye, Turkey
5. University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Clinic of Cardiology, İstanbul, Turkey
No information available.
No information available
Received Date: 10.10.2022
Accepted Date: 23.04.2023
Publish Date: 15.06.2023
PDF
Cite
Share
Request

ABSTRACT

Objective:

Idiopathic dilated cardiomyopathy (IDCM), one of the major causes of chronic heart failure, is a disorder that causes impairment of the systolic function due to left ventricular dilatation without coronary artery disease. In this study, we aimed to investigate retinal vascular density (VD) and the foveal avascular zone (FAZ) area changes in patients with IDCM using optical coherence tomography angiography (OCTA).

Method:

Forty-eight patients with IDCM and a left ventricle ejection fraction below 50% (Group 1) and 50 healthy individuals (Group 2) were evaluated using OCTA. FAZ area, superficial and the deep parafoveal VDs and peripapillary area VDs were measured and compared between the groups.

Results:

The FAZ values were significantly higher in Group 1 (0.29±0.09, 0.20±0.05; p<0.001, respectively). Moreover, the mean VD values were significantly lower in the deep capillary plexus of the parafoveal area in Group 1 (49.05±3.81, 54.81±2.88; p<0.001, respectively). The mean VD values were also significantly lower in the peripapillary area in Group 1 (50.54±3.38, 54.66±1.42; p<0.001, respectively).

Conclusion:

OCTA may possess the potential to be used in the follow-up of this patient group.

Keywords:
Dilated cardiomyopathy, heart failure, microvascular density, optical coherence tomography angiography

Introduction

Chronic heart failure (CHF) is a severe disease in which the feeding of tissue is impaired as a result of the loss of the heart’s pumping function due to various reasons (1). Although the pathogenesis of CHF remains uncertain, it is thought to be associated with microvascular dysfunction (2-6). Idiopathic dilated cardiomyopathy (IDCM), one of the major causes of CHF, is a disorder that causes impairment of the systolic function due to left ventricular dilatation without coronary artery disease (CAD) (7,8). As a spontaneous consequence of the impaired pumping function of the heart, the circulation in the tissues is also impaired (1).

The retina is unique in that it allows for the monitoring of the effects of systemic diseases in vivo. Retinal vascular alterations can be evaluated using different imaging methods. For this reason, many previous studies have been conducted to reveal the effects of cardiac diseases, such as CHF and hypertension (HT), on retinal and choroidal tissues (9-13).

Optical coherence tomography angiography (OCTA) is a new imaging method to assess retinal vascularization. In recent years, many OCTA studies have reported that retinal microvascularization is affected by systemic diseases. OCTA studies have also revealed retinal vascular impairment in patients with CAD, congenital heart disease, (CHD), and CHF (14-16).

In the current study, we tried to reveal the changes in the retinal vascular network quantitatively in patients with IDCM for the first time.

Materials and Methods

This study received approval from the Ethics Committee of University of Health Sciences Turkey, Şişli Hamidiye Etfal Training and Research Hospital and was conducted under the Declaration of Helsinki (05/02/2019; 2245). Based on a study conducted with a similar subject and methodology, at least 37 participants in each group should be included in the study, according to the power analysis result when α: 0.05, and power (1-β): 0.80 were taken with the G*Power 3.1 program. All participants stated that they agreed to participate in the study with written consent. Patients who are followed in cardiology clinic between February 2019 and June 2019 have been evaluated. Patients with no CAD were determined by coronary angiography and a dilated left ventricle cavity with left ventricle ejection fraction (LVEF) below 50% were documented by echocardiography (echo) included in the study. All patients were stratificated according to New York Heart Association (NYHA) functional classification (17,18). Exclusion criteria were: 1) history of congenital diseases, 2) systemic diseases and conditions that might affect the retina [HT, diabetes mellitus (DM), systemic inflammatory diseases, systemic corticosteroids], 4) history of ocular trauma or surgeries, uveitis, optic nerve pathologies, macular degeneration or another ocular pathology, respectively.

Patients were referred from the cardiology clinic to the ophthalmology clinic for the study. An ophthalmological examination was performed for each patient. Patients who are involved in this study had 1) a refractive error < ±2D, 2) a best corrected visual acuity of 20/20, 3) an intraocular pressure lower than 21, 4) a cup-to-disc ratio ≤0.3.

The control group formed by volunteers without additional pathology. Two groups were thus formed: 1) a IDCM group, 2) a control group.

Imaging Protocol

OCTA images were obtained using the AngioVue Imaging System version 2017.1 (Optovue, Inc., Fremont, CA, USA). Foveal avascular zone (FAZ) area, foveal and parafoveal vascular density (VD) determined by the device. Superficial capillary plexus (SCP) and the deep capillary plexus (DCP) were segmented automatically. VDs measured in the optic disc region contained the radial peripapillary capillary (RPC) density. Scans with a signal strength index <70 were excluded. Previous articles have describe the algorithm (19,20).

Statistical Analysis

SPSS version 26.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for analyses. Mean, standard deviation and percentage were used for descriptive statistics. Chi-square test and independent t-test were used to comparison of the datas.

Results

Right eyes of 98 participants were included in the study. The IDCM group included 48 patients and the control group were formed with 50 patients. Table 1 represents the demographic and clinical features of the participants.

Table 2 shows the imaging results. FAZ values in the IDCM group were significantly higher (p<0.001). There was no significant difference between the SCP density values ​​of the two groups (p>0.05 for all). However, the DCP and RPC density values of the IDCM group were significantly lower in all quadrants of peripapillary area (Figure 1).

Discussion

Decreases in ocular blood flow and choroidal thickness in patients with CHF as well as retinal arteriolar narrowing due to HT, myocardial infarction, and CHF have been reported in previous studies (9,10,21-23). It has also been shown that retinal arteriolar narrowing and retinopathy findings can be used to predict CHF risk in patients with HT and CHD (22-24).

The low cardiac output due to impaired ventricular function causes compensatory vasoconstriction in the peripheral tissues to ensure feeding in more critical tissues, such as the brain and heart (25,26). Low perfusion also causes vasospasms and vasoconstriction in the ocular vessels. In addition, Almeida-Freitas et al. (21) showed ophthalmic artery blood flow impairment in patients with CHF in their Doppler study. Alnawaiseh et al. (16) found that retinal perfusion was correlated with LVEF in their OCTA study on CHF.

Based on these findings, we evaluated the data of IDCM patients considering that OCTA may reveal peripheral microvascular changes in patients with CHF. Our study revealed FAZ enlargement and an impairment in the DCP and RPC densities in patients with IDCM.

In their research on patients with CAD, Wang et al. (14) found a decrease in parafoveal VD and proposed that this was associated the location of the occluded coronary artery. However, coronary microvascular dysfunction has been shown in patients with signs of myocardial ischemia without CAD via angiography and even in asymptomatic patients with cardiovascular risk factors in previous studies (4,27). An animal study supports these results (28). In addition, left ventricular dysfunction and heart failure are thought to occur as a result of microvascular processes (5,6). Wang et al. (14) stated that OCTA can be used to detect early-stage CHF. As in our study, the results of the OCTA study of Li et al. (29) on patients with CHD revealed decreased VD in the DCP and RPC, especially among cyanotic patients, although there were no decreases in the SCP density.

The difference between the SCP and the DCP ischemic findings could be due to their specific structures and locations. In their OCTA study on rhegmatogenous retinal detachment, Woo et al. (30) proposed that perfusion pressure may be higher in the SCP, as its branches leave the retinal artery earlier than those of the DCP, and the DCP may be particularly vulnerable to tissue hypoxia and pressure changes (31,32). OCTA studies on DM and HT have shown that VD decreases specifically in the DCP as well as FAZ enlargement, similar to our results (33,34). In contrast, Rakusiewicz et al. (35) found a decrease in the SCP (not the DCP) density in their OCTA study in children with IDCM, stating that this was an unexpected result. We believe that the difference between the results is due to the difference between the patient groups. Although there is no consensus yet, VD decreases due to LVEF decreases can be demonstrated quantitatively with OCTA; therefore, we presume that OCTA may be useful in the follow-up of this patient group in addition to echo.

Although there are several possible explanations, underlying etiological mechanisms in the relationship between optic neuropathies and ocular ischemia remain unknown. In terms of vascular factors, it has been suggested that there may be insufficient blood supply to nourish the optic nerve (36,37). OCTA is insufficient to demonstrate the aetiology of decreased VD in the RPC. Nevertheless, in regard to our study, two possible explanations for this decrease are the loss of vascular structure and vasoconstriction as a result of chronic hypoxia and endothelial dysfunction. Excessive overlapping of radial capillaries near the optic disc may have caused errors in our results. In addition, the fact that retinal nerve fibre layer thickness was not evaluated in our study may have negatively affected our results.

Study Limitations

There was another limitation in our study. The number of participants decreased due to the exclusion of patients with additional systemic disease and poor-quality images. Prospective studies are needed to better understand microvascular changes in this patient group. With continued advances in technology, peripheral retinal VD changes may perhaps be observed via OCTA in the future.

Conclusion

The results of our study revealed a VD decrease in the DCP and RPC in addition to FAZ enlargement in patients with IDCM. Our results suggest that OCTA may possess the potential to be used in the follow-up of this patient group.

Ethics

Ethics Committee Approval: This study received approval from the Ethics Committee of University of Health Sciences Turkey, Şişli Hamidiye Etfal Training and Research Hospital (05/02/2019;2245).
Informed Consent: All participants stated that they agreed to participate in the study with written consent.
Peer-review: Externally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: A.A.A., E.D., M.K., M.E.K., D.Ö., S.S., Concept: A.A.A., E.D., M.K., M.E.K., D.Ö., S.S., Design: A.A.A., E.D., M.K., M.E.K., D.Ö., S.S., Data Collection or Processing: A.A.A., E.D., M.K., M.E.K., D.Ö., S.S., Analysis or Interpretation: A.A.A., E.D., M.K., M.E.K., D.Ö., S.S., Literature Search: A.A.A., E.D., M.K., M.E.K., D.Ö., S.S., Writing: A.A.A., E.D., M.K., M.E.K., D.Ö., S.S.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study received no financial support.

References

1
Remme WJ, Swedberg K; Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22(17):1527-1560. Erratum in: Eur Heart J 2001;22(23):2217-2218.
2
McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med 2010;362(3):228-238.
3
Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348(20):2007-2018.
4
Chilian WM. Coronary microcirculation in health and disease. Summary of an NHLBI workshop. Circulation 1997;95(2):522-528.
5
Gavin JB, Maxwell L, Edgar SG. Microvascular involvement in cardiac pathology. J Mol Cell Cardiol 1998;30(12):2531-2540.
6
Liu PP, Mak S, Stewart DJ. Potential role of the microvasculature in progression of heart failure. Am J Cardiol 1999;84(4A):23L-26L.
7
Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation 2016;134(23):e579-e646. Erratum in: Circulation 2016;134(23):e652.
8
Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34(33):2636-2648, 2648a-2648d.
9
Altinkaynak H, Kara N, Sayın N, Güneş H, Avşar S, Yazıcı AT. Subfoveal choroidal thickness in patients with chronic heart failure analyzed by spectral-domain optical coherence tomography. Curr Eye Res 2014;39(11):1123-1128.
10
Cheung N, Bluemke DA, Klein R, Sharrett AR, Islam FM, Cotch MF, et al. Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis. J Am Coll Cardiol 2007;50(1):48-55.
11
Wang L, Wong TY, Sharrett AR, Klein R, Folsom AR, Jerosch-Herold M. Relationship between retinal arteriolar narrowing and myocardial perfusion: multi-ethnic study of atherosclerosis. Hypertension 2008;51(1):119-126.
12
Tedeschi-Reiner E, Strozzi M, Skoric B, Reiner Z. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol 2005;96(8):1107-1109.
13
Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, et al. Retinopathy and risk of congestive heart failure. JAMA 2005;293(1):63-69.
14
Wang J, Jiang J, Zhang Y, Qian YW, Zhang JF, Wang ZL. Retinal and choroidal vascular changes in coronary heart disease: an optical coherence tomography angiography study. Biomed Opt Express 2019;10(4):1532-1544.
15
Li C, Zhong P, Yuan H, Dong X, Peng Q, Huang M, et al. Retinal microvasculature impairment in patients with congenital heart disease investigated by optical coherence tomography angiography. Clin Exp Ophthalmol 2020;48(9):1219-1228.
16
Alnawaiseh M, Eckardt F, Mihailovic N, Frommeyer G, Diener R, Rosenberger F, et al. Ocular perfusion in patients with reduced left ventricular ejection fraction measured by optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol 2021;259(12):3605-3611.
17
White PD, Myers MM. The classification of cardiac diagnosis. JAMA 1921;77(18):1414-1415.
18
Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981;64(6):1227-1234.
19
Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 2015;133(1):45-50.
20
Jia Y, Bailey ST, Hwang TS, McClintic SM, Gao SS, Pennesi ME, et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A 2015;112(18):E2395-E2402.
21
Almeida-Freitas DB, Meira-Freitas D, Melo LA Jr, Paranhos A Jr, Iared W, Ajzen S. Color Doppler imaging of the ophthalmic artery in patients with chronic heart failure. Arq Bras Oftalmol 2011;74(5):326-329.
22
Wong TY, Klein R, Klein BE, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 2001;46(1):59-80.
23
Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004;351(22):2310-2317.
24
Marcus ML, Chilian WM, Kanatsuka H, Dellsperger KC, Eastham CL, Lamping KG. Understanding the coronary circulation through studies at the microvascular level. Circulation 1990;82(1):1-7.
25
Almeida OP, Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001;31(5):290-295.
26
Zelis R, Sinoway LI, Musch TI, Davis D, Just H. Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants. Am J Cardiol 1988;62(8):2E-8E.
27
Kaufmann PA, Gnecchi-Ruscone T, Schäfers KP, Lüscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36(1):103-109.
28
Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 1990;81(5):1586-1593.
29
Li C, Zhong P, Yuan H, Dong X, Peng Q, Huang M, et al. Retinal microvasculature impairment in patients with congenital heart disease investigated by optical coherence tomography angiography. Clin Exp Ophthalmol 2020;48(9):1219-1228.
30
Woo JM, Yoon YS, Woo JE, Min JK. Foveal Avascular Zone Area Changes Analyzed Using OCT Angiography after Successful Rhegmatogenous Retinal Detachment Repair. Curr Eye Res 2018;43(5):674-678.
31
Adhi M, Filho MA, Louzada RN, Kuehlewein L, de Carlo TE, Baumal CR, et al. Retinal Capillary Network and Foveal Avascular Zone in Eyes with Vein Occlusion and Fellow Eyes Analyzed With Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci 2016;57(9):OCT486-OCT494.
32
Pichi F, Sarraf D, Arepalli S, Lowder CY, Cunningham ET Jr, Neri P, et al. The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res 2017;59:178-201.
33
Sun C, Ladores C, Hong J, Nguyen DQ, Chua J, Ting D, et al. Systemic hypertension associated retinal microvascular changes can be detected with optical coherence tomography angiography. Sci Rep 2020;10(1):9580.
34
Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S. Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2016;254(6):1051-1058.
35
Rakusiewicz K, Kanigowska K, Hautz W, Ziółkowska L. The Impact of Chronic Heart Failure on Retinal Vessel Density Assessed by Optical Coherence Tomography Angiography in Children with Dilated Cardiomyopathy. J Clin Med 2021;10(12):2659.
36
Celik C, Tokgöz O, Serifoğlu L, Tor M, Alpay A, Erdem Z. Color Doppler Evaluation of the Retrobulbar Hemodynamic Changes in Chronic Obstructive Pulmonary Disease: COPD and Retrobulbar Hemodynamic Changes. Ultrason Imaging 2014;36(3):177-186.
37
Ozer T, Altin R, Ugurbas SH, Ozer Y, Mahmutyazicioglu K, Kart L. Color Doppler evaluation of the ocular arterial flow changes in chronic obstructive pulmonary disease. Eur J Radiol 2006;57(1):63-68.